... (TD). ICM can induce hyperthyroidism (Hyper) or hypothyroidism (Hypo) due to supraphysiological concentrations of iodine in the contrast solution. The prevalence of ICM-induced TD varies from 1 to 15%. ICM-induced Hyper is predominantly found in regions with iodine deficiency and in patients...

... change. Fig. 3. Pregnancies with maternal hyperthyroidism and/or ATD medication by year. ATD, antithyroid drug. Fig. 3. Pregnancies with maternal hyperthyroidism and/or ATD medication by year. ATD, antithyroid drug. Fig. 4. Joinpoint analyses of pregnancies with ATD medication by year...

...Lucia Russo; Thi Ngoc Huyen Nguyen; Aglaia Kyrilli; Martin Robin; Pierre Bel Lassen; Rodrigo Moreno-Reyes; Bernard Corvilain Objective: Endogenous subclinical hyperthyroidism (eSCH) is defined by subnormal serum thyroid-stimulating hormone (TSH) level. There is limited evidence of metabolic changes...

...Jesper Karmisholt; Allan Carlé; Stig Andersen Background: Weight gain during treatment of hyperthyroidism is a frequent and for many patients unwanted outcome. With this repeated measurement study, we explored the timing of weight changes during the first year of antithyroid drug (ATD) treatment...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Graves’ disease Hyperthyroidism Marine-Lenhart syndrome Thyroid nodule Toxic adenoma The Marine-Lenhart...

... for hyperthyroidism. Thyroid function, high-sensitive troponin I (hsTnI), and brain natriuretic peptide (BNP) were measured at baseline and then every 3 months for 1 year. Results: Data from a total of 143 patients (median age, 42 years; 32 men and 111 women) were investigated. At baseline, median hsTnI was 1.9 pg/mL...

...Clotilde Saïe; Cécile Ghander; Samir Saheb; Christel Jublanc; Denis Lemesle; Charlotte Lussey-Lepoutre; Laurence Leenhardt; Fabrice Menegaux; Christophe Tresallet; Camille Buffet Introduction: Hyperthyroid patients who are unresponsive to medical treatment remain a challenging clinical problem...

... of the existing discrepancies between results of observational studies and randomized controlled trials. Thyroid function Pregnancy Hyperthyroidism Hypothyroidism [email protected] 11 12 2019 28 01 2020 10 3 2020 © 2020 European Thyroid Association Published by S. Karger AG...

...Diana Grove-Laugesen; Sofie Malmstroem; Eva Ebbehoj; Anne Lene Riis; Torquil Watt; Lars Rejnmark; Klavs Würgler Hansen Introduction and Objective: The excess cardiovascular morbidity and mortality in hyperthyroidism and Graves’ disease (GD) is inadequately understood. We aimed to elucidate whether...

... side effect profile. Radiation-induced thyroiditis can occur in 1–5% of hyperthyroid patients and usually resolves on its own. It usually manifests within 2 weeks of radioiodine (RAI) administration and can be painful but is more commonly painless [ 1-3 ]. Corticosteroids have been used...

...’ disease Guidelines Highly active antiretroviral therapy Hashimoto’s thyroiditis Hyperthyroidism Hypothyroidism Immune reconstitution Management Thyroid Treatment Guidelines Eur Thyroid J 2019;8:173 185 DOI: 10.1159/000500881 Received: January 8, 2019 Accepted after revision: April 29, 2019...

... from any ideas, methods, instructions or products referred to in the content or advertisements. Thyroid dysfunction Hyperthyroidism Hypothyroidism Weight gain Weight loss The incidence of body weight change (BWC) in patients with overt thyroid dysfunction exceeds 50%, representing one...

...Allan Carlé; Nils Knudsen; Torben Jørgensen; Bettina Thuesen; Jesper Karmisholt; Stine Linding Andersen; Inge Bülow Pedersen Objective: To investigate the association between reproductive history and later development of various nosological subtypes of overt hyperthyroidism. Study Design: From...

... significance of autoantibodies to thyroid peroxidase (TPOAb; positive ≥6 kIU/L), free-thyroxine and thyrotropin (combined: euthyroid, hypothyroid, hyperthyroid) was evaluated for disease-free survival (DFS), overall-survival (OS), and time-to-recurrence (TTR), with Cox regression models in univariate...

... of receiving treatment. We report a case of tremelimumab-induced Graves hyperthyroidism in a 55-year-old man who was diagnosed with metastatic melanoma after 8 years of tremelimumab therapy. He had no personal or family history of thyroid or autoimmune diseases. His biochemical profile was in keeping...

...Bernard Goichot; Stéphane Bouée; Claire Castello-Bridoux; Philippe Caron Background: Considerable variations in diagnosis and therapeutic practices are reported for hyperthyroidism (HT) between countries. Methods: A clinical study was conducted among a representative sample of 263 endocrinologists...

...Tetsuya Mizokami; Katsuhiko Hamada; Tetsushi Maruta; Kiichiro Higashi; Junichi Tajiri Background: Radiation thyroiditis caused by 131 I therapy for Graves' hyperthyroidism is asymptomatic in most patients and is rarely associated with pain or fever. Currently, there are few reports...

... in endocrine clinical practice. In particular, overt hyperthyroidism may be complicated by serious adverse events and requires careful treatment, but its management has changed over the years in both the USA and European Union (EU). Objectives: To evaluate the current diagnosis and management of patient's...

... an effect of experimentally induced hyperthyroidism on brain gray matter in healthy adult humans. Methods: High-resolution 3D T1-weighted images were acquired in 29 healthy young subjects prior to as well as after receiving 250 µg of T 4 per day for 8 weeks. Voxel-based morphometry analysis was performed...

...Kathrin Engels; Helena Rakov; Denise Zwanziger; Lars C. Moeller; Georg Homuth; Josef Köhrle; Klaudia Brix; Dagmar Führer Background: Clinical features of thyroid dysfunction vary with age, and an oligosymptomatic presentation of hyperthyroidism is frequently observed in the elderly. This suggests...